| |
| |
|
| Insider
Information: |
Donenberg Philip B |
| Relationship: |
Director |
| City: |
Lincolnshire |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
162,233 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,980,655 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
162,233 |
|
|
| Total
Value |
$2,980,655 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ANI Pharmaceuticals Inc |
ANIP |
Sr. VP of Finance, CFO... |
2011-08-08 |
44,322 |
2003-08-04 |
0 |
Premium* |
|
|
Avexis, Inc. |
AVXS |
Chief Financial Officer |
2018-05-15 |
3,800 |
2018-03-13 |
0 |
Premium* |
|
|
Taysha Gene Therapies, Inc. |
TSHA |
Director |
2023-08-16 |
114,111 |
2022-02-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TSHA |
Taysha Gene Therapies, In... |
Director |
– • – |
2023-08-16 |
4 |
B |
$0.90 |
$100,000 |
D/D |
111,111 |
114,111 |
2.39 |
- |
|
| TSHA |
Taysha Gene Therapies, In... |
Director |
– • – |
2022-02-02 |
4 |
B |
$7.78 |
$23,340 |
D/D |
3,000 |
3,000 |
2.39 |
- |
|
| AVXS |
Avexis, Inc. |
Chief Financial Officer |
• – – |
2018-05-15 |
4 |
|
$0.00 |
$0 |
D/D |
3,800 |
3,800 |
0 |
- |
|
| AVXS |
Avexis, Inc. |
Chief Financial Officer |
• – – |
2018-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,800 |
3,800 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
Sr. VP of Finance, CFO & Secy |
• – – |
2011-08-08 |
4 |
B |
$2.23 |
$2,230 |
D/D |
1,000 |
44,322 |
2.66 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
Sr. VP of Finance, CFO & Secy |
• – – |
2011-08-05 |
4 |
B |
$2.19 |
$2,190 |
D/D |
1,000 |
43,322 |
2.66 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
Sr. VP of Finance, CFO & Secy |
• – – |
2011-01-21 |
4 |
B |
$1.88 |
$1,880 |
D/D |
1,000 |
42,322 |
2.66 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
Sr. VP of Finance, CFO & Secy |
• – – |
2011-01-19 |
4 |
B |
$1.88 |
$1,880 |
D/D |
1,000 |
41,322 |
2.66 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
CFO, Treasurer and Secretary |
• – – |
2008-12-31 |
4 |
B |
$1.00 |
$3,000 |
D/D |
3,000 |
40,322 |
2.66 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
CFO, Treasurer and Secretary |
• – – |
2008-07-29 |
4 |
OE |
$2.15 |
$1,075 |
D/D |
500 |
37,322 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
CFO, Treasurer and Secretary |
• – – |
2007-12-14 |
4 |
B |
$3.73 |
$3,755 |
D/D |
1,000 |
36,822 |
2.66 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
CFO, Treasurer and Secretary |
• – – |
2006-07-20 |
4 |
B |
$1.94 |
$1,949 |
D/D |
1,000 |
35,822 |
2.66 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
CFO, Treasurer and Secretary |
• – – |
2006-03-27 |
4 |
D |
$3.83 |
$120,032 |
D/D |
(31,340) |
34,822 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
CFO, Treasurer and Secretary |
• – – |
2006-03-27 |
4 |
OE |
$2.30 |
$120,032 |
D/D |
52,188 |
66,162 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
CFO, Treasurer and Secretary |
• – – |
2003-08-04 |
4 |
B |
$2.15 |
$2,150 |
D/D |
1,000 |
13,974 |
2.66 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
